Rationale and design of a multicenter randomized study comparing the efficacy and safety of esaxerenone versus trichlormethiazide in patients with uncontrolled essential hypertension: EXCITE‐HT study

The next‐generation mineralocorticoid receptor blocker (MRB) esaxerenone has favorable antihypertensive effects in patients who do not respond to treatment with first‐line antihypertensive agents and may be beneficial as a second‐line treatment. However, MRBs are currently considered a fourth‐line t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kario, Kazuomi, Ohishi, Mitsuru, Katsuya, Tomohiro, Taguchi, Takashi, Tanabe, Ayumi, Sugimoto, Kotaro, Shimosawa, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497029/
https://www.ncbi.nlm.nih.gov/pubmed/37551054
http://dx.doi.org/10.1111/jch.14705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497029/
https://www.ncbi.nlm.nih.gov/pubmed/37551054
http://dx.doi.org/10.1111/jch.14705

Ejemplares similares